Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine vs Olopatadine in Seasonal Allergic Conjunctivitis
NCT01344083Phase 2Completed
- Sponsor
- Laboratoires Théa
- Start
- Apr 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bilastine in seasonal allergic conjunctivitis (SAC), sponsored by Laboratoires Théa. Started Apr 2011; status: completed.
02
Drugs
bilastine
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT01344083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01344083.